US 8497274
Heterocyclic compound and use thereof
granted A61PA61P35/00A61P35/04
Quick answer
US patent 8497274 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00, A61P35/04, A61P43/00